Inclusion Criteria:  Patients aged 18 years or older and with histologically confirmed neuroendocrine tumors; Metastatic or inoperable disease; Patients with clinical information about the therapies received, including exclusive palliative care.  Exclusion Criteria:  Lack of data on survival outcomes and/or details on treatments received.